Cybin Inc. (OTCMKTS:CLXPF – Get Free Report) hit a new 52-week high during mid-day trading on Friday . The stock traded as high as $9.75 and last traded at $9.60, with a volume of 329618 shares traded. The stock had previously closed at $9.88.
Cybin Stock Down 2.8 %
The firm has a market cap of $1.43 billion and a P/E ratio of -41.17. The company’s 50 day simple moving average is $1.38 and its 200-day simple moving average is $0.70.
Cybin Company Profile
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Featured Articles
- Five stocks we like better than Cybin
- How Can Investors Benefit From After-Hours Trading
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- 3 Grocery Stocks That Are Proving They Are Still Essential
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- What is a Bond Market Holiday? How to Invest and Trade
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
